Cite

HARVARD Citation

    Sautto, G. et al. (2016). Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein. Gut. 65 (3), pp. 512-523. [Online]. 
  
Back to record